Skip to main content
SpringerLink
Log in

Chronic Urticaria

  • Chapter
Book cover Urticaria and Angioedema

Core Messages

  • Chronic urticaria is heterogeneous in its course, clinical picture and underlying causes.

  • Autoreactivity, infection and food intolerance are the most common causes.

  • Treatment should be aimed at curing the condition whenever possible. This requires the identification of the underlying cause.

  • Non-sedating H1-antihistamines are the first-line symptomatic treatment. The goal is to completely prevent urticaria symptoms from reoccurring, which requires updosing of antihistamines or the use of additional or other therapies in many patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schäfer T, Simon D, Vena GA, Wedi B. EAACI/GA(2)LEN/ EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64:1427–43

    Article  PubMed  CAS  Google Scholar 

  2. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol. 1981;104:369–81

    Article  PubMed  CAS  Google Scholar 

  3. Maurer M, Ortonne J-P, Zuberbier T. Chronic urticaria: an internet survey on health behaviors, symptom patterns, and treatment needs in european adult patients. Br J Dermatol. 2009;160:633–41

    Article  PubMed  CAS  Google Scholar 

  4. Iffländer J, editor. Akute Urtikaria—Ursachen, Verlauf und Therapie. Dissertation (Med. Doct.). Berlin: Humboldt University; 1999

    Google Scholar 

  5. Zuberbier T, Münzberger CH, Haustein U, Trippas E, Mariz SD, Czarnetzki BM. Double-blind crossover study of high dose cetirizine in cholinergic urticaria. Dermatology 1996;193:324–7

    Article  PubMed  CAS  Google Scholar 

  6. Zuberbier T, Iffländer J, Semmler C, Czarnetzki BM. Acute urticaria—clinical aspects and therapeutic responsiveness. Acta Derm Venereol. 1996;76:295–7

    PubMed  CAS  Google Scholar 

  7. Haas N, Birkle-Berlinger W, Henz BM. Prognosis of acute urticaria in children. Acta Derm Venereol. 2005;85:74–5

    Article  PubMed  Google Scholar 

  8. Zuberbier T. Urticaria. Allergy 2003;58:1224–34

    Article  PubMed  CAS  Google Scholar 

  9. Paul E, Greilich KD. Zur Epidemiologie der Urtikariaerkrankungen. Hautarzt 1991;42:366–75

    PubMed  CAS  Google Scholar 

  10. Gaig P, Olona M, Munoz Lejarazu D, Caballero MT, Dominguez FJ, Echechipia S, Garcia Abujeta JL, Gonzalo MA, Lleonart R, Martinez Cocera C, Rodriguez A, Ferrer M. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol. 2004;14:214–20

    CAS  Google Scholar 

  11. Ogunbiyi AO, Owoaje E, Ndahi A. Prevalence of skin disorders in school children in Ibadan, Nigeria. Pediatr Dermatol. 2005;22:6–10

    Article  PubMed  CAS  Google Scholar 

  12. Vazquez Nava F, Almeida Arvizu VM, Sanchez Nuncio HR, Villanueva Carreto Mde L, Guidos Fogelbach GA. Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico. Rev Alerg Mex. 2004;51:181–8

    PubMed  Google Scholar 

  13. Maurer M. Allergie vom Soforttyp (Typ I)—Mastzellen und Frühphasenreaktion. In: Saloga J, Klimek L, Buhl R, Mann W, Knop J, editors. Allergologie-Handbuch Grundlagen und klinis-che Praxis. Stuttgart: Schattauer; 2006. p. 70–81

    Google Scholar 

  14. Metz M, Bergmann P, Zuberbier T, Maurer M. Successful treatment of cholinergic urticaria with anti-IgE therapie. Allergy 2008;63:143–250

    Article  Google Scholar 

  15. Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008;213:251–60

    Article  PubMed  CAS  Google Scholar 

  16. Maurer M, Metz M, Magerl M, Siebenhaar F, Staubach P. Autoreactive urticaria and autoimmune urticaria. Hautarzt 2004;55:350–6

    Article  PubMed  CAS  Google Scholar 

  17. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeir P. EAACI/GA2LEN task force consensus report: the autologous serum skin test in Urticaria. Allergy 2009;64:1256–68

    Article  PubMed  CAS  Google Scholar 

  18. Metz M, Giménez-Arnau A, Borzova E, Grattan CE, Magerl M, Maurer M. Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol 2009;123:705–6

    Article  PubMed  Google Scholar 

  19. Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, Opper B, Magerl M, Lüdtke R, Kromminga A, Maurer M. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006;212:150–9

    Article  PubMed  CAS  Google Scholar 

  20. Cribier B. Urticaria and hepatitis. Clin Rev Allergy Immunol. 2006;30:25–9

    Article  PubMed  Google Scholar 

  21. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. 2003;49:861–4

    Article  PubMed  Google Scholar 

  22. Barahona RL, Maguina VC, Naquira VC, et al Human blastocystosis: prospective study symptomatology and associated epidemiological factors. Rev Gastroenterol Peru. 2003;23:29–35

    Google Scholar 

  23. Champion RH, Roberts SOB, Carpenter RG, Roger JH. Urticaria and angio-edema: a review of 554 patients. Br J Dermatol. 1969;81:588–97

    Article  PubMed  CAS  Google Scholar 

  24. Ergon MC, Ilknur T, Yucesoy M, Ozkan S. Candida spp. colonization and serum anticandidal antibody levels in patients with chronic urticaria. Clin Exp Dermatol. 2007;32:740–3

    Article  PubMed  CAS  Google Scholar 

  25. Maurer M, Metz M, Magerl M, Siebenhaar F, Staubach P. Relevance of food allergies and intolerance reactions as causes of urticaria. Hautarzt 2003;54:138–43

    PubMed  CAS  Google Scholar 

  26. Buhner S, Reese I, Kuehl F, Lochs H, Zuberbier T. Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability. Allergy 2004;59:1118–23

    Article  PubMed  CAS  Google Scholar 

  27. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008;63:777–80

    Article  PubMed  CAS  Google Scholar 

  28. Bajaj AK, Saraswat A, Upadhyay A, Damisetty R, Dhar S. Autologous serum therapy in chronic urticaria: old wine in a new bottle. Indian J Dermatol Venereol Leprol. 2008;74:109–13

    Article  PubMed  CAS  Google Scholar 

  29. Liu C, Zhou J, Zhang LD, Wang YX, Kang ZM, Chen YZ, Jiang CL. Rapid inhibitory effect of cor-ticosterone on histamine release from rat peritoneal mast cells. Horm Metab Res. 2007;39(4):273–7

    Article  PubMed  CAS  Google Scholar 

  30. Harrison CA, Bastan R, Peirce MJ, Munday MR, Peachell PT. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506. Br J Pharmacol. 2007;150(4):509–18

    Article  PubMed  CAS  Google Scholar 

  31. Stellato C, De Paulis A, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol. 1992;98:800–4

    Article  PubMed  CAS  Google Scholar 

  32. Grattan CE, O’Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, Kobza Black A, Greaves MW. Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol. 2000;143(2):365–72

    Article  PubMed  CAS  Google Scholar 

  33. Kolde G, Frosch PJ, Czarnetzki BM. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol. 1984;83:175–8

    Article  PubMed  CAS  Google Scholar 

  34. Yen A, Gigli I, Barrett KE. Modulation of human cutaneous mast cell responsiveness by a single, low-dose, PUVA treatment. J Allergy Clin Immunol. 1991;88:395–401

    Article  PubMed  CAS  Google Scholar 

  35. Hannuksela M, Kokkonen EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol. 1985;65:449–50

    PubMed  CAS  Google Scholar 

  36. Olafsson JH, Larko O, Roupe G, Granerus G, Bengtsson U. Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study. Acta Dermatol Res. 1986;278:228–31

    Article  CAS  Google Scholar 

  37. Thormann J, Laurberg G, Zachariae H. Oral sodium cromoglycate in chronic urticaria. Allergy 1980;35:139–41

    Article  PubMed  CAS  Google Scholar 

  38. Grattan CEH, Francis DM, Slater NGP, Barlow RJ, Greaves MW. Plasmapheresis for severe unremitting chronic urticaria. Lancet 1992;339:1078–80

    Article  PubMed  CAS  Google Scholar 

  39. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664–672

    Article  PubMed  CAS  Google Scholar 

  40. O’Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, Barlow RJ, Winkelmann RK, Greaves MW. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. 1998;138:101–6

    Article  PubMed  Google Scholar 

  41. Lippert U, Möller A, Welker P, Artuc M, Grützkau A, Henz BM. Inhibition of cytokine secretion from human mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol. 2000;9:118–24

    Article  PubMed  CAS  Google Scholar 

  42. Siebenhaar F, Degener F, Zuberbier T, Martus M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allegy Clin Immynol 2009;123:672–9

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Allergy, Allergie-Centrum-Charité/ECARF, Charité—Universitäts-medizin Berlin, Charitéplatz 1, Berlin, 10117, Germany

    Marcus Maurer

Authors
  1. Marcus Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcus Maurer .

Editor information

Editors and Affiliations

  1. Department of Dermatology and Allergy Allergy-centre-Charité, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany

    Torsten Zuberbier (Prof. Dr. med.) & Marcus Maurer (Prof. Dr. med.) (Prof. Dr. med.) &  (Prof. Dr. med.)

  2. Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, NR4 7UY, United Kingdom

    Clive E. H. Grattan MA, MD, FRCP

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Maurer, M. (2010). Chronic Urticaria. In: Zuberbier, T., Grattan, C.E.H., Maurer, M. (eds) Urticaria and Angioedema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79048-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79048-8_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79047-1

  • Online ISBN: 978-3-540-79048-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation